AstraZeneca PLC (LSE:AZN) signed an agreement to acquire respiratory preparations portfolio from Takeda Pharmaceutical Company Limited (TSE:4502) on January 29, 2018. As part of the transaction AstraZeneca PLC will acquire portfolio of all respiratory products made by Takeda Pharmaceutical Company Limited. The transaction is expected to close in first quarter of 2018.

AstraZeneca PLC (LSE:AZN) cancelled the acquisition of respiratory preparations portfolio from Takeda Pharmaceutical Company Limited (TSE:4502) on January 29, 2019.